Almost certainly not below cost. And the US isn't paying for the R&D (that sounds like a regurgitated line from somewhere?) so much as paying for the pharma co

Almost certainly not below cost. And the US isn't paying for the R&D (that sounds like a regurgitated line from somewhere?) so much as paying for the pharma company's profits, due to the US's totally screwed-up healthcare system and situation.